Articles On Suda Pharmaceuticals (ASX:SUD)
Title | Source | Codes | Date |
---|---|---|---|
SUDA Pharmaceuticals inks deal with Cann Pharmaceutical to develop medical cannabis oral spray
Drug delivery specialist SUDA Pharmaceuticals (ASX: SUD) has finalised a deal with medical cannabis company Cann Pharmaceutical Australia that will see the pair develop an oro-mucosal spray to treat drug-resistant epilepsy, melanoma and mot... |
SmallCaps | SUD | 5 years ago |
10 at 10: These ASX stocks are off to the races this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
SUDA Pharmaceuticals Proposed Share Consolidation for Effective Capital Structure
Based in the United States and Australia, SUDA Pharmaceuticals Ltd (ASX: SUD) is a leading drug delivery company of the world engaged in the reformulation of existing medications and delivery of drugs via the oral mucosa. To reformulate the... |
Kalkine Media | SUD | 5 years ago |
SUDA Prospers Via Drug Delivery Partnerships: A Quick Review of Deals Transacted for ZolpiMistTM
Oro-mucosal drug delivery giant, SUDA Pharmaceuticals Limited (ASX: SUD) is engaged in the pharmaceutical development of drug delivery technology. To increase bioavailability, the company is reformulating the existing drugs into oral sprays... |
Kalkine Media | SUD | 5 years ago |
10 at 10: These ASX stocks are moving and shaking this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
10 at 10: These ASX stocks are off to a flyer this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
10 at 10: These 10 stocks are off to a head start today
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
Weed Week: The first cannabis cafe just opened in the US, complete with resident ‘flower hosts’
Kicking back at your favourite cafe and smoking a joint is an activity historically associated with pot-friendly cities such as Amsterdam. But as of this week, that right has now been extended to US citizens with the grand opening of Americ... |
Stockhead | SUD | 5 years ago |
Rise & Shine: What you need to know before the ASX opens
On Stockhead today: Tim Treadgold on why gold miner Pantoro is a stock to watch, milk stocks in healthier shape thanks to Bellamy’s, Barry FitzGerald talks Salt Lake Pot Ash in Explorer’s Podcast and just how much do neobanks scare the Big... |
Stockhead | SUD | 5 years ago |
Insight into Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceutical’s FY19 Annual Report
Australian-headquartered global pharmaceutical leader, SUDA Pharmaceuticals Limited (ASX: SUD) is engaged in the reformulation of existing drugs and provision of medication via the oral mucosa. The company uses its exclusive OroMist® techno... |
Kalkine Media | SUD | 5 years ago |
New leadership for SUDA Pharmaceuticals
SUDA Pharmaceuticals (ASX SUD), a company focused on oro-mucosal drug delivery, has announced the appointment of Paul Hopper as interim executive chairman to succeed Stephen Carter. |
BiotechDispatch | SUD | 5 years ago |
Dr Boreham’s Crucible: PharmAust wants a piece of the $US10.2b pet drug market
The notion of ‘everything old is new again’ applies not just to fickle fashion trends, but to drug development as well. Drug reformulations are all the rage and it’s not such a bad thing. Think of Paradigm Biopharmaceuticals (ASX:PAR) with... |
Stockhead | SUD | 5 years ago |
Top 10 at 10: These ASX stocks are surprising this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
10 at 10: These ASX stocks are swooping higher this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceuticals Releases Preliminary Final Report
Drugs intake in the form of pills, capsules, and tablets are not the most efficient ways of taking medicine, because only about 25% of the drug reaches where it should. Several factors including food affect, enzymatic degradation, drug meta... |
Kalkine Media | SUD | 5 years ago |
10 at 10: These ASX stocks are being rescued this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
SUDA Makes Speedy Progress with its Robust Product Pipeline
SUDA Pharmaceuticals Ltd (ASX: SUD) is transforming the drug delivery technology to improve the lifestyle and health of the global community by offering innovative and high-quality oro-mucosal spray pharmaceutical products to aid in the tre... |
Kalkine Media | SUD | 5 years ago |
Rise & Shine: What you need to know before the ASX opens
On Stockhead today, what small fries can learn from big health caps, an expert’s view of where crypto is headed, and Barry FitzGerald gets his heavy metal on. But first, here’s what you need to know. The day ahead Australian labour market... |
Stockhead | SUD | 5 years ago |
SUDA’s Science Advisory Board Member, Dr Richard Franklin Joins as Project Director of Anagrelide Project
SUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery company headquartered in Perth, focusses on developing low-risk oral sprays using its proprietary OroMist® oro-mucosal technology to reformulate the existing medications. The... |
Kalkine Media | SUD | 5 years ago |
Imugene Goes Great Guns with Strong Management Team
Imugene Limited (ASX: IMU), an Australian-headquartered clinical-stage immuno-oncology company, focusses on the development of emerging immunotherapies to enhance the efficacy of cancer treatments. The company utilises its unique platform t... |
Kalkine Media | SUD | 5 years ago |
Rise & Shine: What you need to know before the ASX opens
On Stockhead today, will cobalt prices surge after another big mine gets mothballed, the tech and pot stocks still surging after IPOs, and the infant formula maker that reckons it’s “ready to capitalise”. But first, here’s what you need to... |
Stockhead | SUD | 5 years ago |
10 at 10: These ASX stocks are roaring this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
SUDA welcomes Australian Government’s Initiatives to Foster Medical Marijuana Industry
To increase the bioavailability of administered medications, Australian-headquartered SUDA Pharmaceuticals Ltd (ASX: SUD) is reformulating medications into an oral spray. The delivery of medications through the oral mucosa increases the amo... |
Kalkine Media | SUD | 5 years ago |
10 at 10: These 10 stocks are looking well-nourished today
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
Weed Week: Federal government takes steps to fast track medical marijuana licences
The federal government has taken steps to cut red tape and speed up the granting of licences for Australia’s cannabis players. Health Minister Greg Hunt said the federal government would boost the nation’s medicinal cannabis industry by pri... |
Stockhead | SUD | 5 years ago |
Rise & Shine: What you need to know before the ASX opens
On Stockhead today – mining lithium from seawater, our monthly dairy stocks update, and why Hot Copper’s not leading the stocks chat space anymore. But first here’s what you need to know. The day ahead It’s the final day of Diggers and Deal... |
Stockhead | SUD | 5 years ago |
SUDA Pharmaceuticals: Pharmacy And Pharmacology Journal Publishes Impressive ZolpiMistTM Clinical Study Results
SUDA Pharmaceuticals Ltd (ASX: SUD) is an oro-mucosal drug delivery company that is reformulating medication into an oral spray to improve the bioavailability of administered medications. By delivering the drugs through the oral mucosa, the... |
Kalkine Media | SUD | 5 years ago |
Top 10 at 10: These ASX stocks are getting in sync this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel... |
Stockhead | SUD | 5 years ago |
SUDA’s June Quarterly Report Out On ASX; A Look At Its Business And Technology
On 31 July 2019, SUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery firm, has released its June quarterly updates on the ASX. SUDA mentioned that it witnessed several key developments during the quarter including restructurin... |
Kalkine Media | SUD | 5 years ago |
SUDA’s MD and CEO, Mr Stephen Carter Back on Board
An oro-mucosal drug delivery company headquartered in Perth, SUDA Pharmaceuticals Ltd (ASX: SUD) uses its OroMist® technology for the development of low-risk oral sprays. The company reformulates the existing pharmaceuticals into an oral sp... |
Kalkine Media | SUD | 5 years ago |
Top 10 at 10: These ASX stocks are launching higher this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel... |
Stockhead | SUD | 5 years ago |
SUDA Receives Patent For The Only Effective Medicine For Platelet Reduction, Anagrelide; Stock Soars 33%
With the rise in cases of the deadly disease cancer creating havoc across the globe, it is the need of the hour for the pharma participants to gear up and provide cure and treatment solutions to this global concern. With the huge market opp... |
Kalkine Media | SUD | 5 years ago |
Health: Patrys takes another step towards clinical trials for cancer-fighting tech
Biotech company Patrys Limited (ASX:PAB) shares got a bump this morning, after some more positive animal tests for its PAT-DX1 cancer treatment. A completed study at Yale School of Medicine shows PAT-DX1 has the potential to improve radiati... |
Stockhead | SUD | 5 years ago |
Top 10 at 10: These ASX stocks are climbing high this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel... |
Stockhead | SUD | 5 years ago |
Top 10 at 10: These ASX stocks are acing it this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
Energy: Armour has the Queensland government’s blessing to prospect for CSG
The Queensland government has formally awarded Authority to Prospect to coal seam gas explorer Armour Energy’s (ASX: AJQ) joint venture with Australia Pacific LNG (APLNG). While APLNG, which is a joint venture of Sinopec, ConocoPhillips and... |
Stockhead | SUD | 5 years ago |
Top 10 at 10: The stocks are starting the week well today
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest early movers in percentage terms. The market opens at 10am... |
Stockhead | SUD | 5 years ago |
Top 10 at 10: These ASX stocks are acing it this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken as at 10:15am, once every stock has commenced trading. Stocks highlighted in... |
Stockhead | SUD | 5 years ago |
Top 10 at 10: These ASX stocks are bouncing high this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
A Glance At Top 20 Cannabis Companies In Australia
Wth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis industry has boomed quite a bit in recent times. Let’s take a quick look at 20 cannabis companies trading on ASX. Cann Group Limited (ASX:... |
Kalkine Media | SUD | 5 years ago |
Top 10 at 10: These ASX stocks are dancing early this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
Top 10 at 10: These stocks are out in front this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | SUD | 5 years ago |
6 Cannabis Stocks For Australia- THC, EOF, MRG, SUD, CPH, EXL
Globally, the cannabis market is estimated to be valued at around USD 150 billion. According to the European Consumer Staples Report released by Barclays in September 2018, the market value could shoot up, and may staggeringly increase to U... |
Kalkine Media | SUD | 5 years ago |
Weed Week: Illinois legalises recreational pot use… and now, the US Feds can’t interfere
This week the US state of Illinois became the first to pass a bill allowing retail sales of recreational marijuana. From the start of 2020, anyone over the age of 21 will be allowed to possess up to 30 grams of cannabis, and adult visitors... |
Stockhead | SUD | 5 years ago |
Top 10 at 10: These ASX stocks are out of the blocks fast this morning
At the start of every trading day, it can be useful to know which stocks are humming out of the gate. Large percentage moves in small caps aren’t uncommon, but sometimes a big announcement can cause a stock to rocket higher (or fall). Stock... |
Stockhead | SUD | 5 years ago |
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the... |
Stockhead | SUD | 5 years ago |
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the... |
Stockhead | SUD | 5 years ago |